Bioelectronics Stock Price, News & Analysis
Company Description
Bioelectronics (OTC Link: BIEL) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $4.9M.
BIEL stock has gained 50.0% over the past year. Shares last traded at $0.0003.
This page provides a comprehensive overview of BIEL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bioelectronics (BIEL) stock last traded at $0.0003. Over the past 12 months, the stock has gained 50.0%. At a market capitalization of $4.9M, BIEL is classified as a micro-cap stock with approximately 24.7B shares outstanding.
Latest News
Bioelectronics has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include management, clinical trial. View all BIEL news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Bioelectronics (BIEL) currently stands at 297.3 thousand shares, down 83.8% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 67%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Bioelectronics (BIEL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BIEL Company Profile & Sector Positioning
Bioelectronics (BIEL) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BIEL often look at related companies in the same sector, including Remsleep Holding (RMSL), Stimcell Energetics (STME), Odyssey Health Inc (ODYY), Kelyniam Global Inc (KLYG), and Adm Tronics (ADMT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BIEL's relative position within its industry.